News & Updates

QUIWI: FLT3 type II inhibitor confers survival advantage in acute myeloid leukaemia

13 Jul 2023 by

The FLT3 type II inhibitor quizartinib, when combined with induction and consolidated therapy and continued for up to 12 cycles, yields survival benefits such as prolonged overall and relapse-free survival in patients with newly diagnosed wild-type acute myeloid leukaemia (AML), as shown in the interim results of the phase II study QUIWI.

QUIWI: FLT3 type II inhibitor confers survival advantage in acute myeloid leukaemia

13 Jul 2023

Does acute kidney injury lead to CKD progression?

13 Jul 2023

Mild to moderate acute kidney injury (AKI) is slightly associated with worsening subsequent kidney function in patients with chronic kidney disease (CKD) following adjustments for pre-AKI estimated glomerular filtration rate (eGFR), proteinuria, and other covariables, with the possibility of no correlation, suggests a study.

Does acute kidney injury lead to CKD progression?

13 Jul 2023

Can cuffless wearable devices track BP changes?

13 Jul 2023 by

A cuffless wearable device may help improve hypertension management if it demonstrates accuracy and clinical utility. However, a recent study has found that a commercially available blood pressure (BP) monitoring device does not accurately track night-time BP decline and medication-induced BP changes.

Can cuffless wearable devices track BP changes?

13 Jul 2023

Factors tied to masked hypertension vary depending on sleep hypertension

13 Jul 2023

The presence of sleep hypertension modifies the sleep-related factors associated with masked hypertension, according to a study.

Factors tied to masked hypertension vary depending on sleep hypertension

13 Jul 2023

TCM shows potential for mild COVID-19 caused by Omicron

13 Jul 2023 by

Longyizhengqi (LYZQ) granule, a traditional Chinese medicine (TCM), might be a promising drug for the treatment of mild COVID-19 caused by the Omicron variant, a prospective study from China suggests.

TCM shows potential for mild COVID-19 caused by Omicron

13 Jul 2023

Pandemic exposure tied to delayed childhood development

13 Jul 2023

Children exposed to the pandemic are likely to exhibit a development delay at age 5 years, according to a study.

Pandemic exposure tied to delayed childhood development

13 Jul 2023

Mirvetuximab soravtansine improves survival in platinum-resistant ovarian cancer

13 Jul 2023 by

Treatment with mirvetuximab soravtansine, an antibody-drug conjugate (ADC) targeting folate receptor-alpha (FRα), led to significantly better survival outcomes in women with platinum-resistant ovarian cancer (PROC) compared with the investigator’s choice of chemotherapy, according to the MIRASOL trial presented at ASCO 2023.

Mirvetuximab soravtansine improves survival in platinum-resistant ovarian cancer

13 Jul 2023

Fremanezumab eases migraine and depressive symptoms

13 Jul 2023 by

Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.

Fremanezumab eases migraine and depressive symptoms

13 Jul 2023

Intravenous lacosamide for seizures well tolerated in children, infants

12 Jul 2023

Treating seizures with intravenous lacosamide appears to be safe and is associated with low rates of adverse events among critically ill children and neonates, as reported in a study.

Intravenous lacosamide for seizures well tolerated in children, infants

12 Jul 2023

Platelet-rich fibrin matrix shows promise for trophic ulcers

12 Jul 2023 by

Platelet-rich fibrin matrix (PRFM) compares favourably with platelet-rich plasma (PRP) in the treatment of chronic trophic ulcer associated with leprosy, as shown in the results of an observer-blind, noninferiority randomized controlled trial.

Platelet-rich fibrin matrix shows promise for trophic ulcers

12 Jul 2023

News & Updates

Filter by Specialty:

Specialty:

QUIWI: FLT3 type II inhibitor confers survival advantage in acute myeloid leukaemia

QUIWI: FLT3 type II inhibitor confers survival advantage in acute myeloid leukaemia

Does acute kidney injury lead to CKD progression?

Does acute kidney injury lead to CKD progression?

Can cuffless wearable devices track BP changes?

Can cuffless wearable devices track BP changes?

Factors tied to masked hypertension vary depending on sleep hypertension

Factors tied to masked hypertension vary depending on sleep hypertension

TCM shows potential for mild COVID-19 caused by Omicron

TCM shows potential for mild COVID-19 caused by Omicron

Pandemic exposure tied to delayed childhood development

Pandemic exposure tied to delayed childhood development

Mirvetuximab soravtansine improves survival in platinum-resistant ovarian cancer

Mirvetuximab soravtansine improves survival in platinum-resistant ovarian cancer

Fremanezumab eases migraine and depressive symptoms

Fremanezumab eases migraine and depressive symptoms

Intravenous lacosamide for seizures well tolerated in children, infants

Intravenous lacosamide for seizures well tolerated in children, infants

Platelet-rich fibrin matrix shows promise for trophic ulcers

Platelet-rich fibrin matrix shows promise for trophic ulcers